Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia

Area of Science:

• Hematology
• Oncology
• Stem Cell Biology

Background:

• Acute myeloid leukemia (AML) is a bone marrow cancer driven by genetic mutations.
• AML evolution involves sequential genetic alterations in hematopoietic cells.
• High-throughput sequencing identified a preleukemic phase preceding AML development.

Purpose of the Study:

• To review the biological and clinical characteristics of preleukemic hematopoietic stem cells (HSCs).
• To explore the evolutionary origins of AML from preleukemic HSCs.
• To identify unexplored questions and motivate future research in preleukemia.

Main Methods:

• Review of existing scientific literature on AML and preleukemia.
• Analysis of genetic alterations in hematopoietic stem cells.
• Examination of biological and clinical data of preleukemic HSCs.

Main Results:

• AML can arise from mutations accumulating in hematopoietic stem cells (HSCs).
• These mutated HSCs, termed "preleukemic HSCs," are the evolutionary precursors to leukemia.
• Understanding preleukemic HSCs offers insights into AML pathogenesis.

Conclusions:

• Preleukemic HSCs are critical for understanding AML development.
• Further research into preleukemic HSCs is needed to address current knowledge gaps.
• This review speculates on future research directions to advance the field.